Conatus raises $6.6M

Conatus Pharmaceuticals, a start-up working on treatments for inflammation and liver disease, has raised $6.6 million of the $27.4 million round it plans to raise altogether, according to a Form D filed with the Securities and Exchange Commission on Nov. 30. The company was founded in July 2005 by the executive management team of Idun Pharmaceuticals following the sale of Idun to Pfizer.